After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out ...
The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of ...
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA ...
Morning Overview on MSN
New mRNA flu shot proves 30%+ more powerful at stopping influenza A
Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy ...
Earlier this month, Health Secretary Robert F. Kennedy Jr. announced he’s cutting nearly $500 million in funding for mRNA vaccine development from the Biomedical Advanced Research and Development ...
Dr. Sarah Boyd, an infectious disease specialist with Saint Luke's Health System, told KCUR that federal cuts to mRNA research and development could cause a setback in pandemic preparedness. Last week ...
The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger RNA, or mRNA, technology. The U.S. Department of Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results